Skip to content

Early Detection of At-risk Septic Patients

An Observational Pilot Study for the Multi-Modality Risk Prediction and Early Identification of Critically Ill Septic Patients in the Emergency Department

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06253325
Acronym
MMICS
Enrollment
60
Registered
2024-02-12
Start date
2024-01-12
Completion date
2025-08-06
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Brief summary

The purpose of this study is to determine whether additional investigations used in other parts of healthcare can be used in the Emergency Department to identify critically ill patients quicker than usual care.

Detailed description

The investigators intend to recruit 56 patients with suspected sepsis who attend the Emergency Department. The investigators want to use a device to monitor tissue oxygen levels when they first come into the Emergency Department as well as the change in tissue oxygen levels when a tourniquet is applied for 3 minutes. The investigators will take novel blood tests when the patient is having their routine bloods. Finally, the investigators will use a special camera to take specialised pictures of the small blood vessels under the tongue which will show blood flow through these vessels. The investigators will follow the recruited patients and determine if our extra data is better at determining who needs critical care. A significant proportion of patients may be too unwell or too distressed to consent to be part of this study. At the earliest opportunity, the investigators will ask patients when they have been stabilised and are able to give consent. If they say no, they will be removed from the study and their care will not be affected by this decision. The results could help us identify septic shock as early as possible so that these unwell patients are identified early and get the correct treatment they need. This could mean starting advanced treatments usually found in the Intensive Care Unit very early on in a patient's journey.

Interventions

DIAGNOSTIC_TESTHand-held video microscope

A handheld video microscope that looks at blood flow through the capillaries of the tongue

DIAGNOSTIC_TESTMeasuring tissue oxygenation

Measuring oxygen content of arteries, capillaries and veins

DIAGNOSTIC_TESTProcalcitonin

Blood test

DIAGNOSTIC_TESTMid-regional proadrenomedullin

Blood test looking at inflammation in the body

Sponsors

University Hospital Southampton NHS Foundation Trust
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Differential diagnosis which includes infection 2. Change in the quick Sequential Organ Failure Assessment (qSOFA) ≥2 or National Early Warning Score 2 (NEWS2) score ≥5 3. Aged ≥18 years

Exclusion criteria

1. Traumatic injury 2. Rockwood frailty score ≥6 3. Critical care therapy previously believed to not be in patient's best interests 4. Critical care therapies-initiated pre-hospital. Critical care therapies defined as: 4.1 Mechanical ventilation 4.2 Vasopressor/inotrope therapy 4.3 Sedation or a general anaesthetic 4.4 Pre-hospital transfusion of blood products 4.5 Extra-corporeal support 5. Advanced directive refusing critical care therapies. 6. Acute cardiac failure 7. Active gastrointestinal bleed 8. Massive pulmonary embolism 9. ICU admission declined by critical care team 10. Treated in an acute hospital \<6 hours before presentation to the Emergency Department

Design outcomes

Primary

MeasureTime frameDescription
Differences in tissue oxygenationUp to 4 hours (from baseline); 28 days (follow-up)The difference in tissue oxygen saturation (StO2) during the vascular occlusion test in the Emergency Department between septic patients who need critical care treatment (CCT) compared to patients requiring ward care. This will be measured in % change per second..

Secondary

MeasureTime frameDescription
Difference in blood flow of the micro-circulation (microvascular flow index)Up to 4 hours (from baseline); 28 days (follow-up)Differences in the flow of blood through small blood vessels underneath the tongue between the difference between septic patients who need critical care treatment (CCT) compared to patients requiring ward care. This will be measured by the Microvascular Flow Index (arbitrary units) which is a validated measurement assessing micro-circulatory flow.
Difference in blood flow of the micro-circulation (perfused vessel density)Up to 4 hours (from baseline); 28 days (follow-up)Differences in the flow of blood through small blood vessels underneath the tongue between the difference between septic patients who need critical care treatment (CCT) compared to patients requiring ward care. This will be measured by the perfused vessel density (measured in mm/mm2) which is a validated measurement assessing micro-circulatory flow.
Difference in blood lactate levelsUp to 4 hours (from baseline); 28 days (follow-up)The difference in the blood tests of lactate between septic patients who need critical care treatment (CCT) compared to patients requiring ward care
Baseline of tissue oxygenationUp to 4 hours (from baseline); 28 days (follow-up)The difference in tissue oxygen saturation (StO2) at baseline in the Emergency Department between septic patients who need critical care treatment (CCT) compared to patients requiring ward care. This will be measured in %.
Difference in blood tests (Procalcitonin)Up to 4 hours (from baseline); 28 days (follow-up)The difference in the blood tests of Procalcitonin (PCT) between septic patients who need critical care treatment (CCT) compared to patients requiring ward care
Correlation of extra investigations with standard patient outcomesUp to 4 hours (from baseline); 28 days (follow-up)Looking at whether tissue oxygenation, buccal microcirculation (blood flow under the tongue) and biomarkers and correlation with clinical outcomes such as organ failure (SOFA) scores, 28-day hospital mortality, and length of hospital and ICU stay.
Difference in blood tests (MR-proADM)Up to 4 hours (from baseline); 28 days (follow-up)The difference in the blood tests of MR-proADM between septic patients who need critical care treatment (CCT) compared to patients requiring ward care

Countries

United Kingdom

Contacts

Primary ContactJames N Ward, BM
wardj@doctors.org.uk+447881967336
Backup ContactAhilanandan Dushianthan, PhD
a.dushianthan@soton.ac.uk+447903943418

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026